Table I.
Grades of Recommendations
Grade of Recommendation | Clarity of Risk /Benefit | Methodological strength of supporting evidence | Implications |
---|---|---|---|
1A | Clear | Randomised controlled trials without important limitations | Strong recommendation; can apply to most patients in most circumstances without reservation |
1C+ | Clear | No randomised controlled trials but strong results from randomised controlled trials can be unequivocally extrapolated, or overwhelming evidence from observational studies | Strong recommendation; can apply to most patients in most circumstances |
1B | Clear | Randomised controlled trials with important limitations (inconsistent results, methodological flaws) | Strong recommendations; likely to apply to most patients |
1C | Clear | Observational studies | Intermediate-strength recommendation; may change when stronger evidence is available |
2A | Unclear | Randomised controlled trials without important limitations | Intermediate-strength recommendation; best action may differ depending on circumstances or patients’ or societal values |
2C+ | Unclear | No randomised controlled trials but strong results from randomised controlled trials can be unequivocally extrapolated, or overwhelming evidence from observational studies | Weak recommendation; best action may differ depending on circumstances or patients’ or societal values |
2B | Unclear | Randomised controlled trials with important limitations (inconsistent results, methodological flaws) | Weak recommendation; alternative approaches likely to be better for some patients under some circumstances |
2C | Unclear | Evidence obtained from respected authorities or from expert committee reports or opinion of the group of experts responsible for these recommendations | Very weak recommendations; other alternatives may be equally reasonable |